Michael Doumas

14.7k total citations · 2 hit papers
308 papers, 6.4k citations indexed

About

Michael Doumas is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Michael Doumas has authored 308 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 141 papers in Cardiology and Cardiovascular Medicine, 129 papers in Endocrinology, Diabetes and Metabolism and 58 papers in Surgery. Recurrent topics in Michael Doumas's work include Blood Pressure and Hypertension Studies (79 papers), Diabetes Treatment and Management (64 papers) and Heart Rate Variability and Autonomic Control (37 papers). Michael Doumas is often cited by papers focused on Blood Pressure and Hypertension Studies (79 papers), Diabetes Treatment and Management (64 papers) and Heart Rate Variability and Autonomic Control (37 papers). Michael Doumas collaborates with scholars based in Greece, United States and United Kingdom. Michael Doumas's co-authors include Charles Faselis, Vasilios Papademetriou, Κonstantinos Imprialos, Vasilios G. Athyros, Konstantinos Stavropoulos, Peter Kokkinos, Στέλλα Δούμα, Asterios Karagiannis, Athanasios Manolis and Jonathan Myers and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Circulation.

In The Last Decade

Michael Doumas

277 papers receiving 6.2k citations

Hit Papers

Diabetes and lipid metabolism 2018 2026 2020 2023 2018 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Doumas Greece 43 2.3k 2.2k 1.3k 808 740 308 6.4k
Giuseppe Rosano Italy 38 1.6k 0.7× 3.4k 1.5× 831 0.7× 697 0.9× 306 0.4× 165 6.5k
Costas Tsioufis Greece 44 1.0k 0.4× 4.4k 2.0× 1.3k 1.1× 870 1.1× 254 0.3× 362 7.3k
Jun Hata Japan 49 1.4k 0.6× 2.1k 1.0× 1.1k 0.9× 1.6k 2.0× 906 1.2× 236 8.3k
Rachel H. Mackey United States 37 1.3k 0.5× 1.9k 0.8× 987 0.8× 720 0.9× 246 0.3× 109 4.8k
Maciej Tomaszewski United Kingdom 32 1.0k 0.5× 2.9k 1.3× 691 0.5× 670 0.8× 209 0.3× 115 6.7k
Kwan‐Dun Wu Taiwan 57 2.6k 1.2× 1.7k 0.8× 2.9k 2.3× 701 0.9× 356 0.5× 371 11.2k
Chul Woo Ahn South Korea 46 3.0k 1.3× 1.6k 0.7× 1.5k 1.2× 1.5k 1.8× 222 0.3× 303 8.5k
Daniel Duprez United States 50 1.3k 0.6× 5.2k 2.3× 1.9k 1.5× 792 1.0× 140 0.2× 285 9.8k
A. Edo Meinders Netherlands 44 1.7k 0.8× 1.4k 0.6× 3.1k 2.4× 1.3k 1.6× 266 0.4× 123 8.7k
Andries J. Smit Netherlands 51 2.2k 1.0× 2.9k 1.3× 1.2k 1.0× 1.0k 1.3× 104 0.1× 205 8.9k

Countries citing papers authored by Michael Doumas

Since Specialization
Citations

This map shows the geographic impact of Michael Doumas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Doumas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Doumas more than expected).

Fields of papers citing papers by Michael Doumas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Doumas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Doumas. The network helps show where Michael Doumas may publish in the future.

Co-authorship network of co-authors of Michael Doumas

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Doumas. A scholar is included among the top collaborators of Michael Doumas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Doumas. Michael Doumas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Theodorakopoulou, Marieta, Konstantinos Stavropoulos, Maria Schoina, et al.. (2025). Structural and Functional Capillary Integrity, Arterial Stiffness and Central Hemodynamics in CKD Patients With and Without Nocturnal Hypertension. American Journal of Hypertension. 38(8). 580–587.
2.
Koufakis, Theocharis, Djordje S. Popovic, Dimitrios Patoulias, et al.. (2025). Interleukin-6-Related Inflammatory Burden in Type 1 Diabetes: Evidence for Elevation with Suboptimal Glycemic Control. Journal of Clinical Medicine. 14(18). 6511–6511.
3.
Nikolaidou, Barbara, Αreti Triantafyllou, Panagiota Anyfanti, et al.. (2025). Nighttime Systolic Blood Pressure a Major Factor of Retinal Vascular Caliber Changes in Patients With Newly Diagnosed Type 2 Diabetes Mellitus. American Journal of Hypertension. 38(4). 217–224. 1 indexed citations
4.
Apostolidis, Emmanouil, Eleni Gavriilaki, Michael Doumas, et al.. (2025). Evaluating Guideline Alignment by Analyzing Patient Profiles of Elderly People with Type 2 Diabetes and Chronic Kidney Disease Treated or Not with SGLT2 Inhibitors. Pharmaceuticals. 18(6). 807–807. 1 indexed citations
5.
Mouselimis, Dimitrios, Constantinos Bakogiannis, Anastasios Tsarouchas, et al.. (2024). Ferric carboxymaltose reduces the burden of arrhythmic events in heart failure with reduced ejection fraction: the role of the non-invasive arrhythmic biomarkers. Hellenic Journal of Cardiology.
6.
Zografou, Ioanna, Athina Pyrpasopoulou, Konstantinos Stavropoulos, et al.. (2024). Presepsin Levels in Infection-Free Subjects with Diabetes Mellitus: An Exploratory Study. Biomedicines. 12(9). 1960–1960. 4 indexed citations
7.
Katsimardou, Alexandra, Dimitrios Patoulias, Ioanna Zografou, et al.. (2023). The Impact of Metabolic Syndrome Components on Erectile Function in Patients with Type 2 Diabetes. Metabolites. 13(5). 617–617. 4 indexed citations
8.
Gavriilaki, Eleni, Αntonios Lazaridis, Panagiota Anyfanti, et al.. (2023). Circulating microvesicles across a population with various degree of cardiovascular burden are associated with systolic blood pressure. Journal of Human Hypertension. 37(12). 1105–1111. 1 indexed citations
9.
10.
Bakogiannis, Constantinos, Dimitrios Mouselimis, Anastasios Tsarouchas, et al.. (2023). Iron Therapy and Severe Arrhythmias in HFrEF: Rationale, Study Design, and Baseline Results of the RESAFE-HF Trial. ESC Heart Failure. 10(2). 1184–1192. 4 indexed citations
11.
Koufakis, Theocharis, Ioanna Zografou, Michael Doumas, & Kalliopi Kotsa. (2023). The Current Place of DPP4 Inhibitors in the Evolving Landscape of Type 2 Diabetes Management: Is It Time to Bid Adieu?. American Journal of Cardiovascular Drugs. 23(6). 601–608. 5 indexed citations
12.
Anyfanti, Panagiota, Αntonios Lazaridis, Barbara Nikolaidou, et al.. (2022). Blunted Microvascular Reactivity in Psoriasis Patients in the Absence of Cardiovascular Disease, as Assessed by Laser Speckle Contrast Imaging. Life. 12(11). 1796–1796. 9 indexed citations
13.
Patoulias, Dimitrios, Christodoulos Papadopoulos, & Michael Doumas. (2022). Meta-Analysis Addressing the Cardiovascular Safety of Daprodustat in Patients With Chronic Kidney Disease Undergoing Dialysis or Not. The American Journal of Cardiology. 170. 166–167. 2 indexed citations
14.
Patoulias, Dimitrios, Christodoulos Papadopoulos, & Michael Doumas. (2022). Meta-Analysis Addressing the Efficacy and Safety of Antiplatelet Agents in Patients With COVID-19. The American Journal of Cardiology. 175. 185–187. 1 indexed citations
15.
Patoulias, Dimitrios, Christodoulos Papadopoulos, George Kassimis, et al.. (2021). Meta-Analysis Addressing the Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Flow-Mediated Dilation in Patients With Type 2 Diabetes Mellitus. The American Journal of Cardiology. 165. 133–135. 5 indexed citations
16.
Patoulias, Dimitrios, Christodoulos Papadopoulos, & Michael Doumas. (2020). Updated meta‐analysis assessing the risk of amputation with sodium‐glucose co‐transporter‐2 inhibitors in the hallmark cardiovascular and renal outcome trials. Diabetes Obesity and Metabolism. 23(4). 1063–1065. 5 indexed citations
17.
Patoulias, Dimitrios, et al.. (2020). Meta-analysis Assessing the Effect of Sodium-Glucose Co-transporter-2 Inhibitors on Left Ventricular Mass in Patients With Type 2 Diabetes Mellitus. The American Journal of Cardiology. 134. 149–152. 5 indexed citations
19.
Patoulias, Dimitrios, Christodoulos Papadopoulos, Konstantinos Stavropoulos, Κonstantinos Imprialos, & Michael Doumas. (2020). Updated Meta-Analysis of Trials Assessing the Cardiovascular Efficacy of Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Black Patients. The American Journal of Cardiology. 137. 133–135. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026